Psychotropic drugs and the risk of fractures in old age: a prospective population-based study
- Guidelines for prescribing psychoactive drugs in the elderly: Part 1. Maletta, Gabe; Dysken, Maurice; Mattox, Kimberly M. // Geriatrics;Sep1991, Vol. 46 Issue 9, p40
Primary care physicians are usually the first to see elderly patients with emotional problems secondary to dementia and other psychiatric disorders. Because these problems often can be treated effectively, physicians should have a working knowledge of the guidelines for optimal use of...
- Guidelines for prescribing psychoactive drugs in the elderly: Part 2. Maletta, Gabe; Dysken, Maurice; Mattox, Kimberly M. // Geriatrics;Sep1991, Vol. 46 Issue 9, p52
Antipsychotic drugs are frequently used (and sometimes overused) to manage behavioral problems, especially in demented patients. All antipsychotics theoretically work through the same mechanism, so drug selection is based primarily on side effect profiles. In this article, we provide prescribing...
- Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. Huybrechts, Krista F.; Rothman, Kenneth J.; Silliman, Rebecca A.; Brookhart, Alan; Schneeweiss, Sebastian // CMAJ: Canadian Medical Association Journal;4/19/2011, Vol. 183 Issue 7, pE411
Background: Despite safety-related concerns, psychotropic medications are frequently prescribed to manage behavioural symptoms in older adults, particularly those with dementia. We assessed the comparative safety of different classes of psychotropic medications used in nursing home residents....
- Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder. Gunasekara, N.S.; Spencer, C.M.; Keating, G.M. // CNS Drugs;2002, Vol. 16 Issue 9, p645
Ziprasidone is a novel antipsychotic agent with a pharmacological profile distinct from that of other currently available novel or classical antipsychotics. In preclinical studies, ziprasidone was predicted to have efficacy against positive, negative and affective symptoms of schizophrenia with...
- New study designs for new antipsychotics. Kahn, S. // Psychopharmacology;2002, Vol. 162 Issue 1, p92
Focuses on study designs for new antipsychotics. Problems in comparing new with older antipsychotics; Questions which need to be addressed in assessing the new antipsychotics.
- Expert consensus-based medication-use evaluation criteria for atypical antipsychotic drugs. Love, Raymond C.; Mackowick, Marie; Carpenter, Daniel; Burks, Emalie J. // American Journal of Health-System Pharmacy;12/1/2003, Vol. 60 Issue 23, p2455
Focuses on medication-use criteria developed for the appropriate use of atypical antipsychotics through a national consensus process utilizing an expert panel. Demonstration of the utility of a consensus-based process in addressing issues and practices not adequately addressed in the scientific...
- ANTIPSYCHOTICS AND VENOUS THROMBOSIS: Dutch experience differs. Kleijer, Bart C.; Heerdink, E. R.; Van Marum, R. J. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/16/2010, Vol. 341 Issue 7777, p793
A letter to the editor is presented about a case-control study on the use of antipsychotics in elderly patients.
- Newer psychotropics and the older patient. Arenson, Christine A.; Wender, Richard C. // Patient Care;1/15/1999, Vol. 33 Issue 1, p151
Focuses on several psychotropic agents. Rational approach to antidepressant therapy; Neuroleptics; Prescription of neuroleptic therapy.
- PSYCHOTROPIC DRUG INDICATIONS. // Monthly Prescribing Reference;Nov2013, Vol. 29 Issue 11, p278
The article present a table which lists several psychotropic drugs cateogaries including atypical antipsychotics, selective serotonin reuptake inhibitors and monoamine oxidase inhibitors.